Katharine Fb Correia
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Katharine Fb Correia has a total of 141 co-authors. Here are the top co-authors by number of shared publications:
Stacey A. Missmer
Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts
26 shared publicationsElizabeth S. Ginsburg
Center for Infertility and Reproductive Surgery, Department of Obstetrics, Gynecology, and Reproductive Biology, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts
8 shared publicationsMark D. Hornstein
Department of Obstetrics, Gynecology and Reproductive Biology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA USA
7 shared publications- Catherine Racowsky
Ostara Scientific Consulting, Montauban, France
6 shared publications Catherine Racowsky
Department of Obstetrics, Gynecology and Reproductive Biology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts
4 shared publications- Leslie V. Farland
Department of Epidemiology and Biostatistics, Mel and Enid Zuckerman College of Public Health, University of Arizona, Tucson, Arizona
4 shared publications
Latest Publications
- Open Access
- 17 August 2026
- Published by Wiley in International Journal of Gynecology & Obstetrics
Association of a single prior cesarean delivery with adverse birth outcomes at a tertiary referral hospital in southwestern Uganda: A secondary analysis of four observational studies
Background: Prior cesarean delivery (CD) is a leading indication for repeat CD and a key driver of rising cesarean rates in Sub‐Saharan Africa. Evidence on associations between prior CD and adverse outcomes in low‐resource settings remains limited. Objective: We examined the association between one prior CD and adverse maternal and perinatal outcomes and examined current delivery mode as a mediator of this association among women delivering at Mbarara Regional Referral Hospital (MRRH), Uganda. Methods: We conducted a secondary analysis of four prospective studies at MRRH (2014–2024). The exposure was having one prior CD, and outcomes included composite adverse maternal outcomes (postpartum hemorrhage, infection, blood transfusion, prolonged hospital stay, and others) and composite adverse perinatal outcomes (stillbirth, neonatal death, preterm birth, low birthweight, low Apgar score, and neonatal intensive care unit admission). We compared the odds of adverse outcomes for women with one prior CD to those with none using multivariable logistic regression. Causal mediation analysis was used to assess whether current CD mediated the effect of prior CD on adverse maternal outcomes. Results: Of 2222 women with at least one prior delivery, 611 (27.5%) had one prior CD. Women with one prior CD more often delivered by cesarean (73.7% vs. 26.4%) and experienced more adverse maternal outcomes (24.5% vs. 15.4%, P < 0.001), including prolonged hospital stay (21.6% vs. 12.7%, P < 0.001). Prior CD was associated with increased odds of adverse maternal outcomes (adjusted odds ratio [aOR]: 1.99, 95% confidence interval [CI]: 1.54–2.57), with 88.9% of this effect mediated through current delivery mode (indirect odds ratio [OR]: 1.78, 95% CI: 1.41–2.25; direct OR: 1.09, 95% CI: 0.79–1.51, P = 0.586). Adverse perinatal outcomes (19.1%) did not differ by prior CD status ( P = 0.28). HIV‐positive serostatus (aOR: 1.29), referral (aOR: 1.69), and low antenatal care (ANC) attendance (aOR: 1.66) independently predicted perinatal outcomes. Conclusion: While prior CD was associated with higher odds of poor maternal outcomes due to repeat cesarean, HIV‐positive serostatus, facility referral, and low ANC attendance (but not prior CD) independently predicted adverse perinatal outcomes. Individualized delivery planning and improving surgical safety for women with prior CD and strengthened antenatal surveillance are critical to reducing maternal and perinatal morbidity at referral facilities in low‐resource settings.
- 17 August 2026
- Published by Wiley in International Journal of Gynecology & Obstetrics
Open AccessAssociation of a single prior cesarean delivery with adverse birth outcomes at a tertiary referral hospital in southwestern Uganda: A secondary analysis of four observational studies
Background: Prior cesarean delivery (CD) is a leading indication for repeat CD and a key driver of rising cesarean rates in Sub‐Saharan Africa. Evidence on associations between prior CD and adverse outcomes in low‐resource settings remains limited. Objective: We examined the association between one prior CD and adverse maternal and perinatal outcomes and examined current delivery mode as a mediator of this association among women delivering at Mbarara Regional Referral Hospital (MRRH), Uganda. Methods: We conducted a secondary analysis of four prospective studies at MRRH (2014–2024). The exposure was having one prior CD, and outcomes included composite adverse maternal outcomes (postpartum hemorrhage, infection, blood transfusion, prolonged hospital stay, and others) and composite adverse perinatal outcomes (stillbirth, neonatal death, preterm birth, low birthweight, low Apgar score, and neonatal intensive care unit admission). We compared the odds of adverse outcomes for women with one prior CD to those with none using multivariable logistic regression. Causal mediation analysis was used to assess whether current CD mediated the effect of prior CD on adverse maternal outcomes. Results: Of 2222 women with at least one prior delivery, 611 (27.5%) had one prior CD. Women with one prior CD more often delivered by cesarean (73.7% vs. 26.4%) and experienced more adverse maternal outcomes (24.5% vs. 15.4%, P < 0.001), including prolonged hospital stay (21.6% vs. 12.7%, P < 0.001). Prior CD was associated with increased odds of adverse maternal outcomes (adjusted odds ratio [aOR]: 1.99, 95% confidence interval [CI]: 1.54–2.57), with 88.9% of this effect mediated through current delivery mode (indirect odds ratio [OR]: 1.78, 95% CI: 1.41–2.25; direct OR: 1.09, 95% CI: 0.79–1.51, P = 0.586). Adverse perinatal outcomes (19.1%) did not differ by prior CD status ( P = 0.28). HIV‐positive serostatus (aOR: 1.29), referral (aOR: 1.69), and low antenatal care (ANC) attendance (aOR: 1.66) independently predicted perinatal outcomes. Conclusion: While prior CD was associated with higher odds of poor maternal outcomes due to repeat cesarean, HIV‐positive serostatus, facility referral, and low ANC attendance (but not prior CD) independently predicted adverse perinatal outcomes. Individualized delivery planning and improving surgical safety for women with prior CD and strengthened antenatal surveillance are critical to reducing maternal and perinatal morbidity at referral facilities in low‐resource settings.
- 5 June 2025
- Published by Springer Nature in Journal of Assisted Reproduction and Genetics
- Vol. 42 (7) , 2387-2396
An analysis of freeze-all cycles to investigate the association between elevated progesterone on day of trigger and oocyte quality
Purpose To investigate whether a premature rise in progesterone at the end of the follicular phase is adversely associated with oocyte quality in IVF cycles. Methods A retrospective cohort study including patients less than or equal to 40 years of age undergoing their first IVF/ICSI cycle between January 2017 and December 2021 with freeze-all involving D5 or D6 blastocysts. Main Outcome Measure(s) Cumulative live birth rate (cLBR) and cumulative sustained implantation rate (cSIR). Result (s) A total of 1,373 IVF/ICSI cycles were included and categorized into progesterone tertiles (T1: 0.10-0.96 ng/ml; T2: 0.97-1.63 ng/ml; T3: 1.64-9.62 ng/ml). The cLBRs for T1, T2, and T3 were 54.0%, 56.6%, and 52.9%, respectively, and the cSIRs were 54.4%, 56.8%, and 53.3%, respectively. After adjustment for age, peak estradiol, and total dose of gonadotropins used, the risk of cLBR was statistically significantly increased for women in T2 (RR 1.19, 95% CI 1.06-1.33) and T3 (RR 1.14, 95% CI 1.01-1.28) compared with T1. Similar results were obtained for cSIR. For cycles with 5-10 oocytes, a statistically significant positive association was observed between T3 progesterone:oocyte ratio for both cLBR (RR 1.78, 95% CI 1.22-2.60) and cSIR (RR 1.80, 95% CI 1.24-2.62) compared with T1 after adjusting for oocyte number, while no such association was observed for cycles with >10 oocytes retrieved (cLBR: RR 0.95, 95% CI 0.84-0.95; cSIR: RR 0.95, 95% CI 0.83-1.08). Conclusion Our findings do not support an adverse association between a premature rise in progesterone and oocyte quality. In normal responders, this rise may be beneficial.
- 5 June 2025
- Published by Springer Nature in Journal of Assisted Reproduction and Genetics
- Vol. 42 (7) , 2387-2396
An analysis of freeze-all cycles to investigate the association between elevated progesterone on day of trigger and oocyte quality
Purpose To investigate whether a premature rise in progesterone at the end of the follicular phase is adversely associated with oocyte quality in IVF cycles. Methods A retrospective cohort study including patients less than or equal to 40 years of age undergoing their first IVF/ICSI cycle between January 2017 and December 2021 with freeze-all involving D5 or D6 blastocysts. Main Outcome Measure(s) Cumulative live birth rate (cLBR) and cumulative sustained implantation rate (cSIR). Result (s) A total of 1,373 IVF/ICSI cycles were included and categorized into progesterone tertiles (T1: 0.10-0.96 ng/ml; T2: 0.97-1.63 ng/ml; T3: 1.64-9.62 ng/ml). The cLBRs for T1, T2, and T3 were 54.0%, 56.6%, and 52.9%, respectively, and the cSIRs were 54.4%, 56.8%, and 53.3%, respectively. After adjustment for age, peak estradiol, and total dose of gonadotropins used, the risk of cLBR was statistically significantly increased for women in T2 (RR 1.19, 95% CI 1.06-1.33) and T3 (RR 1.14, 95% CI 1.01-1.28) compared with T1. Similar results were obtained for cSIR. For cycles with 5-10 oocytes, a statistically significant positive association was observed between T3 progesterone:oocyte ratio for both cLBR (RR 1.78, 95% CI 1.22-2.60) and cSIR (RR 1.80, 95% CI 1.24-2.62) compared with T1 after adjusting for oocyte number, while no such association was observed for cycles with >10 oocytes retrieved (cLBR: RR 0.95, 95% CI 0.84-0.95; cSIR: RR 0.95, 95% CI 0.83-1.08). Conclusion Our findings do not support an adverse association between a premature rise in progesterone and oocyte quality. In normal responders, this rise may be beneficial.
- 23 February 2024
- Published by Elsevier in Fertility and Sterility
- Vol. 121 (6) , 1063-1065
Estimating the number of oocytes to expose to sperm in assisted reproductive technology treatment
- 23 February 2024
- Published by Elsevier in Fertility and Sterility
- Vol. 121 (6) , 1063-1065
Estimating the number of oocytes to expose to sperm in assisted reproductive technology treatment
- 3 January 2023
- Published by American Medical Association (AMA) in JAMA Network Open
- Vol. 6 (1) , e2249395
Development of a Model to Estimate the Optimal Number of Oocytes to Attempt to Fertilize During Assisted Reproductive Technology Treatment
The number of assisted reproductive technology (ART) cycles conducted each year continues to climb, with more than 2.5 million cycles performed worldwide in 2019.1 As the effectiveness of ART has greatly improved over the last few decades, more high-quality embryos are being created in each cycle, and a live birth is achievable with fewer embryos. The percentage of single embryo transfers in the US increased from 18.2% of cycles in 2010 to 77.3% of cycles in 2019.2 Thus, good quality embryos that are not transferred are most often cryopreserved for later use. However, many of these embryos are ultimately not used. In an analysis of more than 400 000 ART cycles in the US between 2004 and 2013, Christianson et al3 found that a total of 1 954 548 embryos had been cryopreserved and more than 1.2 million of those embryos had not been subsequently transferred. Patients must choose between discarding the embryos, donating them to the embryology laboratory for teaching purposes, donating them to another patient, or paying to store the embryos in perpetuity. Patients can feel conflicted about this decision, so continue paying for storage of cryopreserved embryos indefinitely.4-9
- 3 January 2023
- Published by American Medical Association (AMA) in JAMA Network Open
- Vol. 6 (1) , e2249395
Development of a Model to Estimate the Optimal Number of Oocytes to Attempt to Fertilize During Assisted Reproductive Technology Treatment
The number of assisted reproductive technology (ART) cycles conducted each year continues to climb, with more than 2.5 million cycles performed worldwide in 2019.1 As the effectiveness of ART has greatly improved over the last few decades, more high-quality embryos are being created in each cycle, and a live birth is achievable with fewer embryos. The percentage of single embryo transfers in the US increased from 18.2% of cycles in 2010 to 77.3% of cycles in 2019.2 Thus, good quality embryos that are not transferred are most often cryopreserved for later use. However, many of these embryos are ultimately not used. In an analysis of more than 400 000 ART cycles in the US between 2004 and 2013, Christianson et al3 found that a total of 1 954 548 embryos had been cryopreserved and more than 1.2 million of those embryos had not been subsequently transferred. Patients must choose between discarding the embryos, donating them to the embryology laboratory for teaching purposes, donating them to another patient, or paying to store the embryos in perpetuity. Patients can feel conflicted about this decision, so continue paying for storage of cryopreserved embryos indefinitely.4-9
- Open Access
- 7 November 2022
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 228 (3) , 313.e1-313.e8
State insurance mandates for in vitro fertilization are not associated with improving racial and ethnic disparities in utilization and treatment outcomes
- 7 November 2022
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 228 (3) , 313.e1-313.e8
Open AccessState insurance mandates for in vitro fertilization are not associated with improving racial and ethnic disparities in utilization and treatment outcomes
- Retracted
- 18 August 2022
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 229 (3) , 355-356
The impact of insurance mandates on in vitro fertilization utilization, practices, and outcomes: importance of the statistical analysis
- 18 August 2022
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 229 (3) , 355-356
RetractedThe impact of insurance mandates on in vitro fertilization utilization, practices, and outcomes: importance of the statistical analysis
- 1 March 2022
- Published by Elsevier in Fertility and Sterility
- Vol. 117 (3) , 539-547
The association between season, day length, and temperature on clinical outcomes after cryopreserved embryo transfer
- 1 March 2022
- Published by Elsevier in Fertility and Sterility
- Vol. 117 (3) , 539-547
The association between season, day length, and temperature on clinical outcomes after cryopreserved embryo transfer
- Open Access
- 19 May 2020
- Published by Oxford University Press (OUP) in Human Reproduction
- Vol. 35 (5) , 1013-1018
Confounding and effect measure modification in reproductive medicine research
The majority of research within reproductive and gynecologic health, or investigating ART, is observational in design. One of the most critical challenges for observational studies is confounding, while one of the most important for discovery and inference is effect modification. In this commentary, we explain what confounding and effect modification are and why they matter. We present examples illustrating how failing to adjust for a confounder leads to invalid conclusions, as well as examples where adjusting for a factor that is not a confounder also leads to invalid or imprecise conclusions. Careful consideration of which factors may act as confounders or modifiers of the association of interest is critical to conducting sound research, particularly with complex observational studies in reproductive medicine.
- 19 May 2020
- Published by Oxford University Press (OUP) in Human Reproduction
- Vol. 35 (5) , 1013-1018
Open AccessConfounding and effect measure modification in reproductive medicine research
The majority of research within reproductive and gynecologic health, or investigating ART, is observational in design. One of the most critical challenges for observational studies is confounding, while one of the most important for discovery and inference is effect modification. In this commentary, we explain what confounding and effect modification are and why they matter. We present examples illustrating how failing to adjust for a confounder leads to invalid conclusions, as well as examples where adjusting for a factor that is not a confounder also leads to invalid or imprecise conclusions. Careful consideration of which factors may act as confounders or modifiers of the association of interest is critical to conducting sound research, particularly with complex observational studies in reproductive medicine.
- Open Access
- 19 May 2020
- Published by Oxford University Press (OUP) in Human Reproduction
- Vol. 35 (7) , 1499-1504
Choice of statistical model in observational studies of ART
Analyzing data on ART presents unique and sometimes complicated challenges related to choosing the unit(s) of analysis and the statistical model. In this commentary, we provide examples of how these challenges arise and guidance for overcoming them. We discuss the implications of different ways to count treatment cycles, considering the perspectives of research questions, data management and analysis and patient counseling. We present the advantages and disadvantages of different statistical models, and finally, we discuss the definition and calculation of the cumulative incidence of live birth, which is a key outcome of research on ART.
- 19 May 2020
- Published by Oxford University Press (OUP) in Human Reproduction
- Vol. 35 (7) , 1499-1504
Open AccessChoice of statistical model in observational studies of ART
Analyzing data on ART presents unique and sometimes complicated challenges related to choosing the unit(s) of analysis and the statistical model. In this commentary, we provide examples of how these challenges arise and guidance for overcoming them. We discuss the implications of different ways to count treatment cycles, considering the perspectives of research questions, data management and analysis and patient counseling. We present the advantages and disadvantages of different statistical models, and finally, we discuss the definition and calculation of the cumulative incidence of live birth, which is a key outcome of research on ART.
- 1 November 2018
- Published by Oxford University Press (OUP) in American Journal of Epidemiology
- Vol. 187 (11) , 2470-2480
Estimating the Relative Excess Risk Due to Interaction in Clustered-Data Settings
The risk difference scale is often of primary interest when evaluating public health impacts of interventions on binary outcomes. However, few investigators report findings in terms of additive interaction, probably because the models typically used for binary outcomes implicitly measure interaction on the multiplicative scale. One measure with which to assess additive interaction from multiplicative models is the relative excess risk due to interaction (RERI). The RERI measure has been applied in many contexts, but one limitation of previous approaches is that clustering in data has rarely been considered. We evaluated the RERI metric for the setting of clustered data using both population-averaged and cluster-conditional models. In simulation studies, we found that estimation and inference for the RERI using population-averaged models was straightforward. However, frequentist implementations of cluster-conditional models including random intercepts often failed to converge or produced degenerate variance estimates. We developed a Bayesian implementation of log binomial random-intercept models, which represents an attractive alternative for estimating the RERI in cluster-conditional models. We applied the methods to an observational study of adverse birth outcomes in mothers with human immunodeficiency virus, in which mothers were clustered within clinical research sites.
- 1 November 2018
- Published by Oxford University Press (OUP) in American Journal of Epidemiology
- Vol. 187 (11) , 2470-2480
Estimating the Relative Excess Risk Due to Interaction in Clustered-Data Settings
The risk difference scale is often of primary interest when evaluating public health impacts of interventions on binary outcomes. However, few investigators report findings in terms of additive interaction, probably because the models typically used for binary outcomes implicitly measure interaction on the multiplicative scale. One measure with which to assess additive interaction from multiplicative models is the relative excess risk due to interaction (RERI). The RERI measure has been applied in many contexts, but one limitation of previous approaches is that clustering in data has rarely been considered. We evaluated the RERI metric for the setting of clustered data using both population-averaged and cluster-conditional models. In simulation studies, we found that estimation and inference for the RERI using population-averaged models was straightforward. However, frequentist implementations of cluster-conditional models including random intercepts often failed to converge or produced degenerate variance estimates. We developed a Bayesian implementation of log binomial random-intercept models, which represents an attractive alternative for estimating the RERI in cluster-conditional models. We applied the methods to an observational study of adverse birth outcomes in mothers with human immunodeficiency virus, in which mothers were clustered within clinical research sites.